Amanda Sani

Amanda joined Health Advances in 2016 and is a member of the Cell and Gene Therapy group within the Biopharma practice. Amanda has notable expertise in portfolio strategy and opportunity assessments for novel platforms. Amanda co-leads the Market Insights Group at Health Advances, which focuses on refining tools and strategies for qualitative and quantitative research.

Work experience

Amanda’s focus on the rapidly evolving therapeutic areas of oncology, neurology, and immunology has allowed her to think extensively about requirements for validation of platform technologies. Additionally, Amanda is an emerging thought leader in the use of outcomes-based agreements to facilitate adoption of cell and gene therapies.

Education

Amanda holds a Bachelor of Arts in Human Biology, with a concentration in Stem Cell, Developmental, and Cancer Biology from Stanford University.